Get the Stockscreener App
156.30
2.46%
3.76
After Hours:
156.50
0.20
+0.13%
Davita Inc stock is traded at $156.30, with a volume of 1.08M.
It is up +2.46% in the last 24 hours and up +48.00% over the past month.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
See More
Previous Close:
$152.54
Open:
$152.03
24h Volume:
1.08M
Relative Volume:
1.01
Market Cap:
$10.45B
Revenue:
$12.82B
Net Income/Loss:
$936.34M
P/E Ratio:
14.55
EPS:
10.74
Net Cash Flow:
$1.47B
1W Performance:
+3.70%
1M Performance:
+48.00%
6M Performance:
+13.62%
1Y Performance:
+6.51%
1-Day Range:
$151.87
$157.91
1-Week Range:
$146.00
$157.91
52-Week Range:
$101.00
$157.91
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, UHS, ENSG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
156.30 | 10.20B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
529.70 | 117.60B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
239.39 | 20.84B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.46 | 13.08B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
206.10 | 12.77B | 16.08B | 1.20B | 1.06B | 17.82 |
|
ENSG
Ensign Group Inc
|
214.17 | 12.36B | 4.11B | 239.98M | 193.10M | 4.12 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
Davita Healthcare stock hits 52-week high at 157.25 USD - Investing.com UK
Where Does DaVita Stock Rank Among Competitors? - Trefis
DaVita’s 20-Year Fortune Streak And What It Signals For Investors - Yahoo Finance
DaVita Inc.: Why This Quiet Healthcare Stock Just Got Loud for US Investors - AD HOC NEWS
Does DaVita Stock Lead the Pack? - Trefis
DaVita Celebrates 20 Years on Fortune's List of World's Most Admired Companies - ACCESS Newswire
Vanguard Group Inc. Trims Holdings in DaVita Inc. $DVA - MarketBeat
DaVita Inc. to Participate in TD Cowen's 46th Annual Health Care Conference - GuruFocus
DaVita, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Metrics - Markets Mojo
DaVita Stock After Earnings: Hidden Cash Machine or Value Trap? - AD HOC NEWS
Will DaVita’s (DVA) US$5.6 Billion Buybacks and Tech Push Change Its Capital Allocation Narrative - simplywall.st
DaVita Inc. (DVA) Stock Analysis: Navigating the Healthcare Sector with a Strong Return on Equity - DirectorsTalk Interviews
Is DaVita (DVA) Stock Undervalued Right Now? - Yahoo Finance
Is It Too Late To Consider DaVita (DVA) After Its Sharp 30 Day Surge - Yahoo Finance
DaVita Inc. (DVA): A Bull Case Theory - MSN
Aberdeen Group plc Decreases Stake in DaVita Inc. $DVA - MarketBeat
Layoff Watch: Can DaVita Inc continue delivering strong returnsJuly 2025 Rallies & Expert-Curated Trade Recommendations - baoquankhu1.vn
Wall Street Zen Upgrades DaVita (NYSE:DVA) to Buy - MarketBeat
Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term - Yahoo Finance
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Has $2.56 Million Stock Holdings in DaVita Inc. $DVA - Defense World
Zacks.com featured highlights include DaVita, Ford, Centerra, Southwest Airlines and Patria Investments - Yahoo Finance
October 16th Options Now Available For DaVita (DVA) - Nasdaq
DaVita Stock Is Up 35% Since February. Here’s Where Shares Could Go in 2026 - TIKR.com
Skandinaviska Enskilda Banken AB publ Reduces Stock Position in DaVita Inc. $DVA - MarketBeat
Berkshire’s New CEO Just Offloaded DaVita Stocks: Should You Sell Yours Too? - AOL.com
Berkshire's New CEO Just Offloaded DaVita Stocks: Should You Sell Yours Too? - GOBankingRates
A | Will DaVita Inc. stock benefit from M&A2025 Market Overview & Weekly High Return Stock Forecasts - mfd.ru
Todd Asset Management LLC Makes New Investment in DaVita Inc. $DVA - MarketBeat
National Donor Day Spotlight: DaVita Patient Care Technician Donates Kidney - ACCESS Newswire
DaVita Inc. $DVA Shares Sold by Principal Financial Group Inc. - MarketBeat
Why DaVita (DVA) Is Up 5.8% After Massive Buybacks Amid Softer EarningsAnd What's Next - simplywall.st
Can DaVita Stock Hold Up When Markets Turn? - Trefis
National Donor Day Spotlight: DaVita Patient Care Technician Don - GuruFocus
What are DaVita Inc.’s technical support levelsJuly 2025 Closing Moves & Safe Capital Growth Plans - mfd.ru
LSV Asset Management Sells 13,700 Shares of DaVita Inc. $DVA - MarketBeat
Can DaVita Inc. continue delivering strong returnsPortfolio Value Summary & Verified Short-Term Plans - mfd.ru
AlphaQuest LLC Sells 12,031 Shares of DaVita Inc. $DVA - MarketBeat
DaVita Kidney Care Profit Milestone Highlights Emerging Value Based Earnings Mix - Yahoo Finance
The Dialysis Renaissance: How DaVita (DVA) Conquered the GLP-1 Fear and Defined Healthcare Resilience in 2026 - The Chronicle-Journal
Can DaVita Inc. stock double in next 5 yearsWeekly Investment Recap & Accurate Entry/Exit Alerts - mfd.ru
DaVita Inc (DVA) Stock Price Up 3.19% on Feb 11 - GuruFocus
Gains Report: Will DaVita Inc benefit from seasonalityJuly 2025 PostEarnings & Long-Term Capital Growth Strategies - baoquankhu1.vn
Palmetto Grain Brokerage - Palmetto Grain Brokerage
DaVita Stock: Is Wall Street Bullish or Bearish? - Yahoo Finance
The 5 Most Interesting Analyst Questions From DaVita’s Q4 Earnings Call - Yahoo Finance
DaVita Inc. (DVA) Investor Outlook: Analyzing the Healthcare Leader with a 7.73% Upside Potential - DirectorsTalk Interviews
2 Warren Buffett Stocks to Buy Hand Over Fist in 2026 and 1 to Avoid - The Motley Fool
DaVita Dipped 6% After Big Run-Up: Why Analysts See a Path to $210 in 2026 - TIKR.com
DaVita (DVA) Surges as Top Healthcare Gainer in S&P 500 - GuruFocus
DaVita (DVA) Is Up 28.8% After Strong 2026 Guidance And Heavy BuybacksWhat's Changed - simplywall.st
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):